Gábor Bende

6PUBLICATIONS
16CO-AUTHORS
Medical infection agents (incl. prions)Biologically active moleculesGenetically modified horticulture plants
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 10, 2026
Erratum for Bende et al., "The <i>Neosartorya (Aspergillus) fischeri</i> antifungal protein NFAP2 has low potential to trigger resistance development in <i>Candida albicans in vitro</i>".

|Jul 06, 2026
Morphotype-specific susceptibility to <i>Neosartorya</i> (<i>Aspergillus</i>) <i>fischeri</i> antifungal protein 2 is associated with an anabolic transcriptional signature in <i>Candida</i>.

|Jan 06, 2026
Screening the γ-core Motif Peptides of Ascomycetous Antifungal Proteins for Antifungal Activity and Potential Therapeutic Applicability.

John K Karemera, Györgyi Váradi, Gábor Bende

|Dec 07, 2025
Characterization and Biofungicide Potential of a Novel Antifungal defensin, K4CBP6, from Solanum lycopersicum L.

Rebeka Papp, Péter Poór, Zalán Czékus

|Nov 19, 2024
The <i>Neosartorya (Aspergillus) fischeri</i> antifungal protein NFAP2 has low potential to trigger resistance development in <i>Candida albicans in vitro</i>.

Gábor Bende, Nóra Zsindely, Krisztián Laczi

|Feb 19, 2024
Rational Design of Antifungal Peptides Based on the γ-Core Motif of a <i>Neosartorya</i> (<i>Aspergillus</i>) <i>fischeri</i> Antifungal Protein to Improve Structural Integrity, Efficacy, and Spectrum.

Györgyi Váradi, Gábor Bende, Attila Borics

Pageof 1

Frequent Collaborators

6 joint publications

László Galgóczy

3 joint publications

Györgyi Váradi

3 joint publications

Attila Borics

2 joint publications

Kinga Dán